Refine by
Neurology Disease Suppliers & Manufacturers
73 companies found
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the ...
based inWashington, DISTRICT OF COLUMBIA (USA)
We’re pioneering precision neurology by building the world’s leading platform for reliable, accessible, affordable diagnosis and monitoring of neurological diseases. At Altoida, we recognize the need for individuals to understand their brain health ...
Altoida’s medical device for cognitive assessment measures brain health in 10 minutes with a battery of immersive augmented reality (AR) activities. Through a set of tasks that simulate activities of daily living, Altoida’s software ...
based inPittsburgh, PENNSYLVANIA (USA)
Computational Diagnostics, Inc. (CDI) has been pioneering the field of Intraoperative Neurophysiological Monitoring (IOM) since 1988 by providing exceptional patient care. While our technology has changed over the last 25+ years, our commitment to ...
based inOxford, UNITED KINGDOM
Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on improving the natural delivery capabilities of exosomes, and developing an entirely new class of therapeutics. Backed by leading venture capital groups and ...
The second urea cycle disorder indication to be targeted by Evox is Citrullinemia type I, which is caused by a mutation in the ASS1 gene leading to a deficiency in hepatic enzyme arginosuccinate synthetase (ASS) that results in high levels of ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
It is indispensable and effective to use animal disease models in experimental medical research. Animal models of neurological disease provide a convenient and reliable platform for developing new ...
based inMontclair, NEW JERSEY (USA)
Theranica develops advanced, clinically proven, safe and affordable digital therapeutics, addressing some of the world’s most prevalent neurological pain diseases. We harness a pain inhibition mechanism known as Conditioned Pain Modulation (CPM). ...
CPM, Conditioned Pain Modulation, is one of our neural system mechanisms to control pain. CPM is an endogenous descending pain inhibition mechanism, located in the brain stem, the most “primitive” part of the brain, which is a critical ...
based inDessau-Rosslau, GERMANY
IDT Biologika is an international leader in the contract development and manufacture of Viral Vaccines, Viral Vectors for Gene and Immune Therapeutics, Oncolytic Viruses, Virus-Like Particles, and other biologics. We are a full-service biologics ...
IDT Biologika is a leading viral vector CDMO with an exceptional track record in biologics manufacturing, including expertise with live viral agents. This makes us well-positioned to support the rapid growth in gene therapy and immunotherapeutics ...
based inRye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
Patient-centered drug discovery is at the core of what we do at Curemark. We approach neurological disorders from a translational and innovative ...
based inBlankenfelde-Mahlow, GERMANY
Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...
based inLeiden, NETHERLANDS
A leading pioneer in leveraging iPSC innovation for drug discovery. The catalyst with the requisite iPSC know-how and experience to empower innovators in drug discovery to advance their science relentlessly, consistently and efficiently. For the ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inPearl River, NEW YORK (USA)
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a ...
Acorda’s mission is to develop therapies to restore function and improve the lives of people with neurological disorders. Our company is devoted to supporting neurological research, education, and patient assistance through grant and ...
based inPlymouth Meeting, PENNSYLVANIA (USA)
Harmony Biosciences is a commercial-stage pharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare neurological diseases, especially sleep/wake, neurobehavioral, and rare epilepsy disorders. The ...
based inTotowa, NEW JERSEY (USA)
VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
based inViken, SWEDEN
TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...
based inWarszawa, POLAND
TeleNeuroforma is based on 8 years of experience. The exercises used in Neuroforma have already proven themselves in stationary rehabilitation. Hundreds of facilities use the Neuroforma PRO station every day, and thousands of patients have already ...
Practice wherever and whenever you want: Do you want to start home rehabilitation? Just go to the website app.neuroforma.pl, register and you’re done! You can use Neuroforma on your computer or tablet. For exercise, you need an Internet ...
based inHeidelberg, GERMANY
Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...
MiRNAs are small, highly conserved, non-coding RNAs playing crucial roles in the regulation of virtually all aspects of living ...
based inHouston, TEXAS (USA)
Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet ...
The EV71 IgM Rapid Test Cassette is a sandwich lateral flow chromatographic immunoassay for the qualitative detection of IgM-class antibodies to human Enterovirus 71 (EV71) in human whole blood, serum or plasma. It is intended to be used as a ...